Literature DB >> 16671953

The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population.

M Fedetz1, F Matesanz, A Caro-Maldonado, I I Smirnov, V N Chvorostinka, T A Moiseenko, A Alcina.   

Abstract

The 1858T variant of the protein tyrosine phosphatase gene, PTPN22, is associated with an increased risk of several autoimmune diseases. The aim of this study has been to investigate the possible association of 1858C-->T PTPN22 polymorphism and type 1 diabetes (T1D) in Caucasians from Ukraine. Overall, the distribution of 1858 PTPN22 genotypes differed significantly between the T1D patient group (n = 296) and the control group (n = 242) (P = 0.0036). When both groups were classified according to sex, the TT genotype and T allele showed a statistically significant higher frequency in T1D female patients (5.9 and 22.8%, respectively) in comparison with the female controls (0 and 11.9%) (P = 0.008 for both analyses). The patients with the TT genotype were significantly younger at the onset of T1D compared with those with genotypes TC and CC (P = 0.035 and 0.019, respectively). In our Ukrainian Caucasian cohort, we confirmed the association between T1D and the PTPN22,1858T allele.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16671953     DOI: 10.1111/j.1399-0039.2006.00591.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Authors:  M Maziarz; M Janer; J C Roach; W Hagopian; J P Palmer; K Deutsch; C B Sanjeevi; I Kockum; N Breslow; A Lernmark
Journal:  Genes Immun       Date:  2010-05-06       Impact factor: 2.676

2.  Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.

Authors:  A Blasetti; C Di Giulio; S Tumini; M Provenzano; D Rapino; L Comegna; G Prezioso; R Chiuri; S Franchini; F Chiarelli; L Stuppia
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

Review 3.  Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.

Authors:  Stephanie M Stanford; Tomas M Mustelin; Nunzio Bottini
Journal:  Semin Immunopathol       Date:  2010-03-04       Impact factor: 9.623

Review 4.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

5.  HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes.

Authors:  Anna Okruszko; Barbara Szepietowska; Natalia Wawrusiewicz-Kurylonek; Maria Górska; Adam Krętowski; Małgorzata Szelachowska
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

6.  The role of PTPN22 C1858T gene polymorphism in diabetes mellitus type 1: first evaluation in Greek children and adolescents.

Authors:  Styliani Giza; Antonios Goulas; Emmanouela Gbandi; Smaragda Effraimidou; Efimia Papadopoulou-Alataki; Maria Eboriadou; Assimina Galli-Tsinopoulou
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

7.  The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens.

Authors:  Fiona Clarke; Harriet A Purvis; Cristina Sanchez-Blanco; Enrique Gutiérrez-Martinez; Georgina H Cornish; Rose Zamoyska; Pierre Guermonprez; Andrew P Cope
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.